[ad_1]
Moderna is seeking emergency approval for the corona vaccine in the United States today, Monday. Test subjects could be given the second dose of vaccination. Approval for Europe is also expected to start today.
In modern Switzerland, he has already started the lamination procedure at Swissmedic. Furthermore, Switzerland already has a contract with Moderna, which guarantees the delivery of 4.5 million doses of the vaccine.
High efficacy
The Moderna vaccine is 94.1 percent effective, according to the company. This comes from the latest data analysis from the Phase III clinical trial, in which 30,000 people in the United States are participating. The first interim analysis predicted 95 percent effectiveness.
For particularly severe disease courses, the vaccine is even 100% effective. Furthermore, there were no serious side effects. The preparation is equally effective for all age groups.
Biontech and Pfizer are also in the running
The Mainz-based manufacturer Biontech also carried out this procedure together with the US company Pfizer. Biontech and Pfizer have already applied for emergency approval in the US, but not yet in the EU. Moderna’s preparation is relatively similar to the Biontech / Pfizer vaccine in terms of mode of action and efficacy. Like Pfizer and Biontech, the Moderna preparation is a so-called RNA vaccine.
Switzerland could guarantee 5.3 million vaccine doses from Biontech and Pfizer across Sweden.
Source link
